# Lenalidomide Maintenance Post-debulking in Advanced CTCL

> **NCT01098656** · PHASE3 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 21 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT01098656
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** recruitment prematurely halted following company's decision to stop financial support to the study
- **Last updated:** 2018-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01098656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01098656, "Lenalidomide Maintenance Post-debulking in Advanced CTCL". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01098656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*